NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP
Baird Medical Investment Holdings Limited BDMD
4 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$22.5M
▼ 39.2% vs FY2024
EPS · FY25
$-0.98
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-76.8%
Net margin · FY25
-121.0%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 22.5M
Revenue, FY2025 · full 4-year series below
Revenue
Net income
The company lost 121 cents on every revenue dollar this year.
Per share
USD -0.98
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-76.8%
Return on equity, FY2025
ROE
Operating margin-113.7%
Net margin-121.0%
Return on assets-36.9%
Each USD of equity lost 77 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
—
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−13.7%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.03B
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 69.7M
total assets, end of FY2025
Total assetsUSD 69.7M
EquityUSD 31.4M
CashUSD 178,321.00
Gross debtUSD 8.7M
Net debtUSD 8.5M
Current ratio1.70×
Net debt stands at 27% of equity.
History
4 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
Revenue $B
0.0
0.0
0.0
0.0
Operating income $B
−0.0
0.0
0.0
0.0
EBITDA $B
−0.0
0.0
0.0
0.0
Income tax $B
0.0
0.0
0.0
0.0
Net income $B
−0.0
0.0
0.0
0.0
EPS, diluted $
−0.98
0.57
0.51
0.49
Dividend / sh $
·
·
·
·
Payout %
·
·
·
·
ROE %
−76.8
33.0
29.5
·
Shares out B
0.03
0.03
0.03
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
14 of 14
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed